CELEGHINI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 7.616
AS - Asia 3.568
EU - Europa 1.908
SA - Sud America 626
Continente sconosciuto - Info sul continente non disponibili 186
AF - Africa 71
OC - Oceania 11
AN - Antartide 1
Totale 13.987
Nazione #
US - Stati Uniti d'America 7.455
SG - Singapore 1.368
CN - Cina 870
BR - Brasile 498
VN - Vietnam 402
IT - Italia 367
DE - Germania 288
UA - Ucraina 284
TR - Turchia 257
HK - Hong Kong 250
PL - Polonia 230
GB - Regno Unito 200
FI - Finlandia 129
FR - Francia 99
RU - Federazione Russa 83
SE - Svezia 83
CA - Canada 80
IN - India 69
BD - Bangladesh 66
MX - Messico 54
ID - Indonesia 49
JP - Giappone 44
AR - Argentina 43
NL - Olanda 36
ES - Italia 32
IQ - Iraq 31
ZA - Sudafrica 31
EC - Ecuador 26
PK - Pakistan 26
SA - Arabia Saudita 19
CO - Colombia 17
BE - Belgio 14
MY - Malesia 14
UZ - Uzbekistan 14
VE - Venezuela 13
AT - Austria 11
PH - Filippine 11
AU - Australia 9
CL - Cile 9
IR - Iran 9
LT - Lituania 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
EG - Egitto 7
IL - Israele 7
JM - Giamaica 7
NP - Nepal 7
AL - Albania 6
AZ - Azerbaigian 6
CR - Costa Rica 6
JO - Giordania 6
KE - Kenya 6
RO - Romania 6
TH - Thailandia 6
UY - Uruguay 6
DZ - Algeria 5
KZ - Kazakistan 5
PY - Paraguay 5
BO - Bolivia 4
HN - Honduras 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
BH - Bahrain 3
CY - Cipro 3
IE - Irlanda 3
KR - Corea 3
OM - Oman 3
PS - Palestinian Territory 3
PT - Portogallo 3
AO - Angola 2
BG - Bulgaria 2
CH - Svizzera 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BB - Barbados 1
BS - Bahamas 1
DJ - Gibuti 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
ML - Mali 1
Totale 13.793
Città #
Singapore 831
Woodbridge 820
Ashburn 810
Fairfield 712
San Jose 463
Houston 383
Jacksonville 332
Seattle 319
Chandler 306
Cambridge 305
Beijing 288
Santa Clara 274
Wilmington 246
Ann Arbor 245
Hong Kong 245
Warsaw 228
Izmir 138
Ferrara 129
Ho Chi Minh City 123
Los Angeles 113
Dallas 108
Council Bluffs 107
New York 105
Nanjing 96
Hanoi 84
Princeton 76
Boardman 65
Munich 61
Lauterbourg 60
Milan 51
Helsinki 48
Dearborn 41
San Diego 41
Tokyo 39
São Paulo 37
Jakarta 35
Shanghai 35
The Dalles 35
Nanchang 34
Columbus 33
Mexico City 32
Buffalo 31
Orem 31
London 28
Changsha 24
Shenyang 24
Bremen 23
Tianjin 23
Da Nang 22
Frankfurt am Main 22
Johannesburg 22
Montreal 22
Chicago 21
Manchester 21
Turku 21
Chennai 20
Denver 20
Jinan 20
Toronto 20
Mountain View 19
Bologna 17
Brooklyn 17
Haiphong 17
Jiaxing 17
Moscow 16
Falls Church 15
Hebei 15
Stockholm 15
Phoenix 14
San Francisco 14
Boston 13
Brussels 13
Dong Ket 13
Kunming 13
San Mateo 13
Zhengzhou 13
Atlanta 12
Biên Hòa 12
Hefei 12
Leawood 12
Poplar 12
Rio de Janeiro 12
Baghdad 11
Hải Dương 11
Quito 11
Amsterdam 10
Aprilia 10
Falkenstein 10
Norwalk 10
Redwood City 10
Washington 10
Ankara 9
Philadelphia 9
Tappahannock 9
Tashkent 9
Auburn Hills 8
Brasília 8
Calgary 8
Curitiba 8
Ottawa 8
Totale 9.443
Nome #
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 341
Ceramides as the molecular link between impaired lipid metabolism, saturated fatty acid intake and insulin resistance: are all saturated fatty acids to be blamed for ceramide-mediated lipotoxicity? 315
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 293
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 273
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 270
Neuronal dysfunction associated with cholesterol deregulation 270
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry 246
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 234
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 231
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells 229
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 228
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 218
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 218
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies 217
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells 215
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 211
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 208
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 196
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis 191
Total extract of Beta vulgaris var. cicla seeds versus its purified phenolic components: antioxidant activities and antiproliferative effects against colon cancer cells 185
Activation of the nitric oxide synthase pathway represents a key component of the TNF-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity on hematological malignancies. 184
Levels of circulating TNF-related apoptosis-inducing ligand in celiac disease 177
All-Trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients 170
HIV-1 Tat protein suppresses the nerve growth factor (NGF)-mediated differentiation of PC12 rat pheochromocytoma cell line 168
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 164
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 164
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction 164
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. 163
Repositioning of Tak-475 in mevalonate kinase disease: Translating theory into practice 161
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand 157
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 157
Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives 152
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate 151
Subcellular localization of the regulatory HIV-1 Tat protein produced endogenously by or added exogenously to PC12 rat pheochromocytoma and human Jurkat T lymphoid cells 151
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL) 148
In situ polymerase chain reaction technique revealed by flow cytometry as a tool for gene detection 145
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib 143
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 143
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 139
In vivo and in vitro modulatory effect of human immunodeficiency virus type (HIV-1) Tat protein on protein kinase C activity. 139
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 138
Pre-eclampsia affects procalcitonin production in placental tissue 128
Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells. 125
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 125
Differential effects of stromal derived factor-1 alpha (SDF-1alpha) on early and late stages of human megakaryocytic development. 122
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 119
Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells 116
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitus 113
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis. 110
null 105
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 104
MitoQ is able to modulate apoptosis and inflammation 103
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro 101
null 98
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 98
null 97
null 94
The induction of megakaryocyte differentiation is accompanied by selective Ser133 phosphorylation of the transcription factor CREB in both HEL cell line and primary CD34+ cells 94
null 92
Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. 91
Potential role of circulating microRNAs as early markers of preeclampsia 90
null 90
null 90
null 89
null 89
null 89
null 89
null 88
null 88
null 88
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 87
null 86
null 86
null 86
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway 86
null 86
null 86
null 85
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo 84
Purinergic Signaling in Controlling Macrophage and T Cell Functions During Atherosclerosis Development 84
null 83
null 83
Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival 83
null 82
null 81
null 81
Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease 80
null 78
null 76
null 76
null 76
null 76
Tumor necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 71
Impaired survival of bone marrow GPIIb/IIIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia 67
null 66
null 65
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 63
Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes 62
Selective modulation of specific protein kinase C (PKC) isoforms in primary human megakaryocytic vs erythroid cells 61
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 61
Totale 13.319
Categoria #
all - tutte 60.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.092


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022596 0 39 30 26 50 51 41 40 33 73 64 149
2022/2023758 77 43 26 100 122 113 48 44 95 10 34 46
2023/2024359 59 46 12 11 10 49 21 30 7 19 10 85
2024/20251.772 42 25 136 70 240 134 96 107 297 164 260 201
2025/20264.786 471 236 434 610 685 319 541 277 416 564 151 82
2026/2027378 113 265 0 0 0 0 0 0 0 0 0 0
Totale 13.987